SERPINA1 and COVID-19: Given our findings and the previously mentioned studies showing that those with AAT deficiency are more predisposed to severe disease and death from COVID-19, it is reasonable to surmise that AAT augmentation in those with severe AAT deficiency would be beneficial against COVID-19.